Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can reminders and info get more women screened for cancer?

NCT ID NCT07214051

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether providing educational materials and follow-up calls could increase cancer screening rates among women in Puerto Rico who were overdue for breast, cervical, or colorectal cancer screenings. 500 women aged 21-75 took part, with half receiving the intervention. The goal was to see if community-based outreach could overcome barriers like distrust and lack of access.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cancer screening information and reminders
What this could lead to
If successful, this approach could increase cancer screening rates and early detection in underserved communities.
What could go wrong
This is a completed behavioral study, not a drug trial. Results may not apply to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

500 people

The number who actually took part.

Started

Dec 2023

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 75 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women * Between 21 and 75 years old * Participant is overdue in at least one cancer screening (breast, cervical or colorectal), according to the USPTF guidelines. * Participants that have not reported any cognitive, mental or physical limitation. * Ability to read. * Access to a telephone. * Participants that are not in active cancer treatment. Exclusion Criteria: * Male * Women younger than 21 years or older than 75 years. * Participants that are not overdue in any cancer screening (breast, cervical or colorectal), according to the USPTF guidelines. * Participants that are cognitive, mental or physically limited. * Participants who are not able to read. * Participants who don't have access to a telephone. * Participants that are in active cancer treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Puerto Rico, Comprehensive Cancer Center

    San Juan, PR, 00926, Puerto Rico

More trials for these conditions

Other studies related to the condition(s) this trial covers.